COMPOUND HAVING BTK PROTEIN DEGRADATION ACTIVITY, AND MEDICAL USES THEREOF
The present disclosure provides: a compound of a specific chemical structure, having excellent activity with respect to BTK degradation; or a pharmaceutically acceptable salt thereof. The present disclosure also provides a composition comprising the compound or pharmaceutically acceptable salts ther...
Saved in:
Main Authors | , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
11.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides: a compound of a specific chemical structure, having excellent activity with respect to BTK degradation; or a pharmaceutically acceptable salt thereof. The present disclosure also provides a composition comprising the compound or pharmaceutically acceptable salts thereof. The present disclosure also provides are pharmaceutical use for treating or preventing BTK-associated diseases (for example, autoimmune diseases or cancer) of the compound, the salt thereof, and the composition comprising same according to the present disclosure. The present disclosure also provides a method for treating or preventing BTK-associated diseases (for example, autoimmune diseases or cancer), comprising administering, to a subject requiring treatment, an effective amount of the compound, the salt thereof, or the composition comprising same according to the present disclosure.
La présente divulgation concerne : un composé d'une structure chimique spécifique, ayant une excellente activité en termes de dégradation de BTK ; ou un sel pharmaceutiquement acceptable de celui-ci. La présente divulgation concerne également une composition comprenant le composé ou des sels pharmaceutiquement acceptable de celui-ci. La présente divulgation concerne également une utilisation pharmaceutique pour le traitement ou la prévention de maladies associées à BTK (par exemple, des maladies auto-immunes ou un cancer) du composé, du sel de celui-ci, et de la composition le comprenant selon la présente divulgation. La présente divulgation concerne également un procédé de traitement ou de prévention de maladies associées à BTK (par exemple, des maladies auto-immunes ou un cancer), comprenant l'administration, à un sujet nécessitant un traitement, d'une quantité efficace du composé, de son sel, ou de la composition le comprenant selon la présente divulgation. |
---|---|
Bibliography: | Application Number: CA20223237119 |